메뉴 건너뛰기




Volumn 91, Issue 5, 2015, Pages 952-960

Concurrent chemo-radiation with or without induction gemcitabine, carboplatin, and paclitaxel: A randomized, phase 2/3 trial in locally advanced nasopharyngeal carcinoma

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOTHERAPY; CONCURRENCY CONTROL; DISEASE CONTROL; HAZARDS; TOXICITY;

EID: 84925334903     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2015.01.002     Document Type: Article
Times cited : (189)

References (38)
  • 1
    • 0031947875 scopus 로고    scopus 로고
    • Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup study 0099
    • M. Al-Sarraf, M. LeBlanc, and P.G. Giri Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup study 0099 J Clin Oncol 16 1998 1310 1317
    • (1998) J Clin Oncol , vol.16 , pp. 1310-1317
    • Al-Sarraf, M.1    Leblanc, M.2    Giri, P.G.3
  • 2
    • 0037441720 scopus 로고    scopus 로고
    • Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: Positive effect on overall and progression-free survival
    • J.C. Lin, J.S. Jan, and C.Y. Hsu Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: Positive effect on overall and progression-free survival J Clin Oncol 21 2003 631 637
    • (2003) J Clin Oncol , vol.21 , pp. 631-637
    • Lin, J.C.1    Jan, J.S.2    Hsu, C.Y.3
  • 3
    • 15944417086 scopus 로고    scopus 로고
    • Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma
    • A.T. Chan, S.F. Leong, and R.K. Ngan Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma J Natl Cancer Inst 97 2005 536 539
    • (2005) J Natl Cancer Inst , vol.97 , pp. 536-539
    • Chan, A.T.1    Leong, S.F.2    Ngan, R.K.3
  • 4
    • 27244452301 scopus 로고    scopus 로고
    • Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union Against Cancer stage III and IV nasopharyngeal cancer of the endemic variety
    • J. Wee, E.H. Tan, and B.C. Tai Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union Against Cancer stage III and IV nasopharyngeal cancer of the endemic variety J Clin Oncol 23 2005 6730 6738
    • (2005) J Clin Oncol , vol.23 , pp. 6730-6738
    • Wee, J.1    Tan, E.H.2    Tai, B.C.3
  • 5
    • 0344915699 scopus 로고    scopus 로고
    • Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. Radiotherapy alone in stage IV (> or = N2, M0) undifferentiated nasopharyngeal carcinoma: A positive effect on progression-free survival. International Nasopharynx Cancer Study Group. VUMCA i trial
    • International Nasopharynx Cancer Study Group Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV (> or = N2, M0) undifferentiated nasopharyngeal carcinoma: A positive effect on progression-free survival. International Nasopharynx Cancer Study Group. VUMCA I trial Int J Radiat Oncol Biol Phys 35 1996 463 469
    • (1996) Int J Radiat Oncol Biol Phys , vol.35 , pp. 463-469
  • 6
    • 15444347863 scopus 로고    scopus 로고
    • Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Asian-Oceanian Clinical Oncology Association Nasopharynx Cancer Study Group
    • D.T. Chua, J.S. Sham, and D. Choy Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Asian-Oceanian Clinical Oncology Association Nasopharynx Cancer Study Group Cancer 83 1998 2270 2283
    • (1998) Cancer , vol.83 , pp. 2270-2283
    • Chua, D.T.1    Sham, J.S.2    Choy, D.3
  • 7
    • 0035282127 scopus 로고    scopus 로고
    • Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma
    • J. Ma, H.Q. Mai, and M.H. Hong Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma J Clin Oncol 19 2001 1350 1357
    • (2001) J Clin Oncol , vol.19 , pp. 1350-1357
    • Ma, J.1    Mai, H.Q.2    Hong, M.H.3
  • 8
    • 0035576411 scopus 로고    scopus 로고
    • Induction chemotherapy with mitomycin, epirubicin, cisplatin, fluorouracil, and leucovorin followed by radiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma
    • R.L. Hong, L.L. Ting, and J.Y. Ko Induction chemotherapy with mitomycin, epirubicin, cisplatin, fluorouracil, and leucovorin followed by radiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma J Clin Oncol 19 2001 4305 4313
    • (2001) J Clin Oncol , vol.19 , pp. 4305-4313
    • Hong, R.L.1    Ting, L.L.2    Ko, J.Y.3
  • 9
    • 84856918008 scopus 로고    scopus 로고
    • Comparison of concurrent chemoradiotherapy versus induction chemotherapy followed by radiation in patients with nasopharyngeal carcinoma
    • M. Komatsu, M. Tsukuda, and H. Matsuda Comparison of concurrent chemoradiotherapy versus induction chemotherapy followed by radiation in patients with nasopharyngeal carcinoma Anticancer Res 32 2012 681 686
    • (2012) Anticancer Res , vol.32 , pp. 681-686
    • Komatsu, M.1    Tsukuda, M.2    Matsuda, H.3
  • 10
    • 0034309182 scopus 로고    scopus 로고
    • Repopulation of tumour cells between cycles of chemotherapy: A neglected factor
    • A.J. Davis, and J.F. Tannock Repopulation of tumour cells between cycles of chemotherapy: A neglected factor Lancet Oncol 1 2000 86 93
    • (2000) Lancet Oncol , vol.1 , pp. 86-93
    • Davis, A.J.1    Tannock, J.F.2
  • 11
    • 0028278817 scopus 로고
    • Rapid tumor cell proliferation after induction chemotherapy in oropharyngeal cancer
    • J. Bourhis, G. Wilson, and P. Wibault Rapid tumor cell proliferation after induction chemotherapy in oropharyngeal cancer Laryngoscope 104 1994 468 472
    • (1994) Laryngoscope , vol.104 , pp. 468-472
    • Bourhis, J.1    Wilson, G.2    Wibault, P.3
  • 12
    • 66949122761 scopus 로고    scopus 로고
    • Induction chemotherapy with cisplatin and epirubicin followed by radiotherapy and concurrent cisplatin in locally advanced nasopharyngeal carcinoma observed in a non-endemic population
    • M. Airoldi, A.M. Gabriele, and M. Garzaro Induction chemotherapy with cisplatin and epirubicin followed by radiotherapy and concurrent cisplatin in locally advanced nasopharyngeal carcinoma observed in a non-endemic population Radiother Oncol 92 2009 105 110
    • (2009) Radiother Oncol , vol.92 , pp. 105-110
    • Airoldi, M.1    Gabriele, A.M.2    Garzaro, M.3
  • 13
    • 79955557725 scopus 로고    scopus 로고
    • Induction chemotherapy with carboplatin and taxol followed by radiotherapy and concurrent weekly carboplatin + taxol in locally advanced nasopharyngeal carcinoma
    • M. Airoldi, P. Gabriele, and A.M. Gabriele Induction chemotherapy with carboplatin and taxol followed by radiotherapy and concurrent weekly carboplatin + taxol in locally advanced nasopharyngeal carcinoma Cancer Chemother Pharmacol 67 2011 1027 1034
    • (2011) Cancer Chemother Pharmacol , vol.67 , pp. 1027-1034
    • Airoldi, M.1    Gabriele, P.2    Gabriele, A.M.3
  • 14
    • 41749096627 scopus 로고    scopus 로고
    • Induction chemotherapy with paclitaxel and cisplatin, followed by concomitant cisplatin and radiotherapy for the treatment of locally advanced nasopharyngeal carcinoma
    • E. Mostafa, M.N. Nasar, and N.A. Rabie Induction chemotherapy with paclitaxel and cisplatin, followed by concomitant cisplatin and radiotherapy for the treatment of locally advanced nasopharyngeal carcinoma J Egypt Natl Canc Inst 18 2006 348 356
    • (2006) J Egypt Natl Canc Inst , vol.18 , pp. 348-356
    • Mostafa, E.1    Nasar, M.N.2    Rabie, N.A.3
  • 15
    • 75549092146 scopus 로고    scopus 로고
    • Phase II study of docetaxel, cisplatin, and 5-FU induction chemotherapy followed by chemoradiotherapy in locoregionally advanced nasopharyngeal cancer
    • W.K. Bae, J.E. Hwang, and H.J. Shim Phase II study of docetaxel, cisplatin, and 5-FU induction chemotherapy followed by chemoradiotherapy in locoregionally advanced nasopharyngeal cancer Cancer Chemother Pharmacol 65 2010 589 595
    • (2010) Cancer Chemother Pharmacol , vol.65 , pp. 589-595
    • Bae, W.K.1    Hwang, J.E.2    Shim, H.J.3
  • 16
    • 80155124275 scopus 로고    scopus 로고
    • Docetaxel, cisplatin and 5-fluorouracil-based induction chemotherapy followed by intensity modulated radiotherapy concurrent with cisplatin in locally advanced EBV-related nasopharyngeal cancer
    • P. Bossi, E. Orlandi, and C. Bergamini Docetaxel, cisplatin and 5-fluorouracil-based induction chemotherapy followed by intensity modulated radiotherapy concurrent with cisplatin in locally advanced EBV-related nasopharyngeal cancer Ann Oncol 22 2011 2495 2500
    • (2011) Ann Oncol , vol.22 , pp. 2495-2500
    • Bossi, P.1    Orlandi, E.2    Bergamini, C.3
  • 17
    • 58249089750 scopus 로고    scopus 로고
    • Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma
    • E.P. Hui, B.B. Ma, and S.F. Leung Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma J Clin Oncol 27 2009 242 249
    • (2009) J Clin Oncol , vol.27 , pp. 242-249
    • Hui, E.P.1    Ma, B.B.2    Leung, S.F.3
  • 18
    • 84856316834 scopus 로고    scopus 로고
    • Induction chemotherapy followed by concomitant radiotherapy and weekly cisplatin versus the same concomitant chemoradiotherapy in patients with nasopharyngeal carcinoma: A randomized phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluation
    • G. Fountzilas, E. Ciuleanu, and M. Bobos Induction chemotherapy followed by concomitant radiotherapy and weekly cisplatin versus the same concomitant chemoradiotherapy in patients with nasopharyngeal carcinoma: A randomized phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluation Ann Oncol 23 2012 427 435
    • (2012) Ann Oncol , vol.23 , pp. 427-435
    • Fountzilas, G.1    Ciuleanu, E.2    Bobos, M.3
  • 19
    • 27344447760 scopus 로고    scopus 로고
    • Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group
    • A.W. Lee, W.H. Lau, and S.Y. Tung Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group J Clin Oncol 23 2005 6966 6975
    • (2005) J Clin Oncol , vol.23 , pp. 6966-6975
    • Lee, A.W.1    Lau, W.H.2    Tung, S.Y.3
  • 20
    • 33746799334 scopus 로고    scopus 로고
    • Preliminary results of a randomized study (NPC-9902 Trial) on therapeutic gain by concurrent chemotherapy and/or accelerated fractionation for locally advanced nasopharyngeal carcinoma
    • A.W. Lee, S.Y. Tung, and A.T. Chan Preliminary results of a randomized study (NPC-9902 Trial) on therapeutic gain by concurrent chemotherapy and/or accelerated fractionation for locally advanced nasopharyngeal carcinoma Int J Radiat Oncol Biol Phys 66 2006 142 151
    • (2006) Int J Radiat Oncol Biol Phys , vol.66 , pp. 142-151
    • Lee, A.W.1    Tung, S.Y.2    Chan, A.T.3
  • 21
    • 49449113097 scopus 로고    scopus 로고
    • 4th FY Khoo Memorial lecture 2008. Nasopharyngeal Cancer Workgroup - The past, the present and the future
    • J. Wee 4th FY Khoo Memorial lecture 2008. Nasopharyngeal Cancer Workgroup - the past, the present and the future Ann Acad Med Singap 37 2008 606 614
    • (2008) Ann Acad Med Singap , vol.37 , pp. 606-614
    • Wee, J.1
  • 22
    • 0034895749 scopus 로고    scopus 로고
    • Interactions of gemcitabine, carboplatin and paclitaxel in molecularly defined non-small-cell lung cancer cell lines
    • M.J. Edelman, H. Quam, and B. Mullins Interactions of gemcitabine, carboplatin and paclitaxel in molecularly defined non-small-cell lung cancer cell lines Cancer Chemother Pharmacol 48 2001 141 144
    • (2001) Cancer Chemother Pharmacol , vol.48 , pp. 141-144
    • Edelman, M.J.1    Quam, H.2    Mullins, B.3
  • 23
    • 19944433612 scopus 로고    scopus 로고
    • Paclitaxel, carboplatin, and gemcitabine in metastatic nasopharyngeal carcinoma: A Phase II trial using a triplet combination
    • S.S. Leong, J. Wee, and M.H. Tay Paclitaxel, carboplatin, and gemcitabine in metastatic nasopharyngeal carcinoma: A Phase II trial using a triplet combination Cancer 103 2005 569 575
    • (2005) Cancer , vol.103 , pp. 569-575
    • Leong, S.S.1    Wee, J.2    Tay, M.H.3
  • 24
    • 53149111132 scopus 로고    scopus 로고
    • Triplet combination of gemcitabine, paclitaxel, and carboplatin followed by maintenance 5-fluorouracil and folinic acid in patients with metastatic nasopharyngeal carcinoma
    • S.S. Leong, J. Wee, and S. Rajan Triplet combination of gemcitabine, paclitaxel, and carboplatin followed by maintenance 5-fluorouracil and folinic acid in patients with metastatic nasopharyngeal carcinoma Cancer 113 6 2008 Sep 15 1332 1337
    • (2008) Cancer , vol.113 , Issue.6 , pp. 1332-1337
    • Leong, S.S.1    Wee, J.2    Rajan, S.3
  • 25
    • 29244448683 scopus 로고    scopus 로고
    • Chemotherapy in locally advanced nasopharyngeal carcinoma: An individual patient data meta-analysis of eight randomized trials and 1753 patients
    • B. Baujat, H. Audry, and J. Bourhis Chemotherapy in locally advanced nasopharyngeal carcinoma: An individual patient data meta-analysis of eight randomized trials and 1753 patients Int J Radiat Oncol Biol Phys 64 2006 47 56
    • (2006) Int J Radiat Oncol Biol Phys , vol.64 , pp. 47-56
    • Baujat, B.1    Audry, H.2    Bourhis, J.3
  • 26
    • 35548966042 scopus 로고    scopus 로고
    • Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer
    • J.B. Vermorken, E. Remenar, and C. van Herpen Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer N Engl J Med 357 2007 1695 1704
    • (2007) N Engl J Med , vol.357 , pp. 1695-1704
    • Vermorken, J.B.1    Remenar, E.2    Van Herpen, C.3
  • 27
    • 35548972994 scopus 로고    scopus 로고
    • Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer
    • M.R. Posner, D.M. Hershock, and C.R. Blajman Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer N Engl J Med 357 2007 1705 1715
    • (2007) N Engl J Med , vol.357 , pp. 1705-1715
    • Posner, M.R.1    Hershock, D.M.2    Blajman, C.R.3
  • 28
    • 84925303617 scopus 로고    scopus 로고
    • Randomized phase III trial of concurrent chemoradiation with or without neoadjuvant gemcitabine, carboplatin, and paclitaxel in locally advanced nasopharyngeal cancer [abstract]
    • (suppl; abstr 6003
    • Terence Tan, Wan-Teck Lim, Kam-Weng Fong et al. Randomized phase III trial of concurrent chemoradiation with or without neoadjuvant gemcitabine, carboplatin, and paclitaxel in locally advanced nasopharyngeal cancer [abstract]. J Clin Oncol 32:5s, 2014 (suppl; abstr 6003)
    • (2014) J Clin Oncol , vol.32 , pp. 5s
    • Tan, T.1    Lim, W.2    Fong Et Al., K.3
  • 29
    • 0036569761 scopus 로고    scopus 로고
    • Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: An update of the UCSF experience
    • N. Lee, P. Xia, and J.M. Quivey Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: An update of the UCSF experience Int J Radiat Oncol Biol Phys 53 2002 12 22
    • (2002) Int J Radiat Oncol Biol Phys , vol.53 , pp. 12-22
    • Lee, N.1    Xia, P.2    Quivey, J.M.3
  • 30
    • 29244459121 scopus 로고    scopus 로고
    • Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: Update of the Memorial Sloan-Kettering experience
    • S.L. Wolden, W.C. Chen, and D.G. Pfister Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: Update of the Memorial Sloan-Kettering experience Int J Radiat Oncol Biol Phys 64 2006 57 62
    • (2006) Int J Radiat Oncol Biol Phys , vol.64 , pp. 57-62
    • Wolden, S.L.1    Chen, W.C.2    Pfister, D.G.3
  • 31
    • 84867048784 scopus 로고    scopus 로고
    • A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. Conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma
    • G. Peng, T. Wang, and K.Y. Yang A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma Radiother Oncol 104 2012 286 293
    • (2012) Radiother Oncol , vol.104 , pp. 286-293
    • Peng, G.1    Wang, T.2    Yang, K.Y.3
  • 32
    • 84890110008 scopus 로고    scopus 로고
    • Prognostic impact of cigarette smoking on the survival of patients with established nasopharyngeal carcinoma
    • P.Y. Ouyang, Z. Su, and Y.P. Mao Prognostic impact of cigarette smoking on the survival of patients with established nasopharyngeal carcinoma Cancer Epidemiol Biomarkers Prev 22 2013 2285 2294
    • (2013) Cancer Epidemiol Biomarkers Prev , vol.22 , pp. 2285-2294
    • Ouyang, P.Y.1    Su, Z.2    Mao, Y.P.3
  • 33
    • 0037669569 scopus 로고    scopus 로고
    • Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated type
    • S.F. Leung, A.T. Chan, and B. Zee Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated type Cancer 98 2003 288 291
    • (2003) Cancer , vol.98 , pp. 288-291
    • Leung, S.F.1    Chan, A.T.2    Zee, B.3
  • 34
    • 84906818712 scopus 로고    scopus 로고
    • Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer
    • E.E.W. Cohen, T.G. Karrison, and Kocherginsky Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer J Clin Oncol 32 2014 2735 2743
    • (2014) J Clin Oncol , vol.32 , pp. 2735-2743
    • Cohen, E.E.W.1    Karrison, T.G.2    Kocherginsky3
  • 35
    • 84875267472 scopus 로고    scopus 로고
    • Induction chemotherapy followed by concurrent chemotherapy (sequential chemotherapy) versus concurrent chemotherapy alone in locally advanced head and neck cancer (PARADIGM): A randomised phase 3 trial
    • R. Haddad, A. O'Neill, and G. Rabinowits Induction chemotherapy followed by concurrent chemotherapy (sequential chemotherapy) versus concurrent chemotherapy alone in locally advanced head and neck cancer (PARADIGM): A randomised phase 3 trial Lancet Oncol 14 2013 257 264
    • (2013) Lancet Oncol , vol.14 , pp. 257-264
    • Haddad, R.1    O'Neill, A.2    Rabinowits, G.3
  • 36
    • 84899476710 scopus 로고    scopus 로고
    • A randomized phase III trial comparing induction chemotherapy followed by chemotherapy versus chemotherapy alone as treatment of unresectable head and neck cancer
    • R. Hitt, J.J. Grau, and A. Lopez-Pousa A randomized phase III trial comparing induction chemotherapy followed by chemotherapy versus chemotherapy alone as treatment of unresectable head and neck cancer Ann Oncol 25 2014 216 225
    • (2014) Ann Oncol , vol.25 , pp. 216-225
    • Hitt, R.1    Grau, J.J.2    Lopez-Pousa, A.3
  • 37
    • 84925302061 scopus 로고    scopus 로고
    • Plasma EBV DNA as a predictive biomarker in patients with endemic nasopharyngeal carcinoma treated with induction chemotherapy and concurrent chemoradiation therapy [abstract]
    • M. Chua, O. Whee Sze, and J. Wee Plasma EBV DNA as a predictive biomarker in patients with endemic nasopharyngeal carcinoma treated with induction chemotherapy and concurrent chemoradiation therapy [abstract] Int J Radiat Oncol Biol Phys 90 Suppl. 2014 S120 S121
    • (2014) Int J Radiat Oncol Biol Phys , vol.90 , pp. S120-S121
    • Chua, M.1    Whee Sze, O.2    Wee, J.3
  • 38
    • 4444256753 scopus 로고    scopus 로고
    • Another way to estimate outcome of advanced nasopharyngeal carcinoma - Is concurrent chemoradiotherapy adequate?
    • J.C. Lin, W.M. Liang, and J.S. Jan Another way to estimate outcome of advanced nasopharyngeal carcinoma - is concurrent chemoradiotherapy adequate? Int J Radiat Oncol Biol Phys 60 2004 156 164
    • (2004) Int J Radiat Oncol Biol Phys , vol.60 , pp. 156-164
    • Lin, J.C.1    Liang, W.M.2    Jan, J.S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.